Deferiprone‐induced agranulocytosis: 20 years of clinical observations

Use of the iron chelator deferiprone for treatment of iron overload in thalassemia patients is associated with concerns over agranulocytosis, which requires weekly absolute neutrophil counts (ANC). Here, we analyze all episodes of agranulocytosis (n = 161) and neutropenia (n = 250) during deferipron...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Hematol
Hlavní autoři: Tricta, Fernando, Uetrecht, Jack, Galanello, Renzo, Connelly, John, Rozova, Anna, Spino, Michael, Palmblad, Jan
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129477/
https://ncbi.nlm.nih.gov/pubmed/27415835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24479
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky